Month: May 2017

Lexington Biosciences Commences Trading on Canadian Securities Exchange (CSE: LNB)

VANCOUVER, BC–(May 9, 2017) –  Lexington Biosciences, Inc. (CSE: LNB)  (the “Company” or “Lexington“), a development-stage medical device company operating within the healthcare industry, is pleased to announce that the Company has commenced trading on the Canadian Securities Exchange (the “Exchange“) effective May 9, 2017 under the symbol “LNB.” Transaction and Private Placement The Company

Read More



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News